Matches in DBpedia 2014 for { ?s ?p Dr. Chang H. Ahn (Chang Ahn or Chang-Ho Ahn) is the Chairman and Chief Executive Officer of Rexahn Pharmaceuticals, Inc., a publicly listed company (NYSE NYSE MKT: RNN) developing medicines for life-threatening or debilitating diseases such as cancer and brain disorders. Dr. Ahn founded Rexahn in 2001 and led the company to public listing on the American Stock Exchange in 2008, which subsequently merged with the New York Stock Exchange.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Chang_H._Ahn comment "Dr. Chang H. Ahn (Chang Ahn or Chang-Ho Ahn) is the Chairman and Chief Executive Officer of Rexahn Pharmaceuticals, Inc., a publicly listed company (NYSE NYSE MKT: RNN) developing medicines for life-threatening or debilitating diseases such as cancer and brain disorders. Dr. Ahn founded Rexahn in 2001 and led the company to public listing on the American Stock Exchange in 2008, which subsequently merged with the New York Stock Exchange.".